当前位置:上海富雨生物科技有限公司>>细胞库 / 细胞培养>>ATCC细胞>> IPEC-J2 猪小肠上皮细胞
产品名称:IPEC-J2 猪小肠上皮细胞、IPEC-J2 猪小肠上皮细胞、IPEC-J2 猪小肠上皮细胞、IPEC-J2 猪小肠上皮细胞;
猪正常肠上皮细胞IPEC-J2
种属 | 猪 |
别称 | IPECJ2; Intestinal Porcine Epithelial Cell line-J2 |
组织来源 | 肠(空肠) |
疾病 | 正常 |
传代比例/细胞消化 | 1:2传代 ,消化1-3分钟 |
培养基配置 | DMEM培养基;10%胎牛血清;1%双抗 |
简介 | 该细胞从一只新生的未感染猪空肠分离的正常肠上皮细胞中建立 ,经历一个自发的分化过程 ,在1-2周内形成具有低或 高跨上皮电阻(TEER)的极化单层 ,这取决于加入培养基的血清类型。 |
形态 | 上皮细胞样 |
生长特征 | 贴壁生长 |
倍增时间 | 每周 2 至 3 次 |
培养条件 | 气相:空气 ,95% ;二氧化碳 ,5%。 温度:37摄氏度 ,培养箱湿度为70%-80%。 |
冻存条件 | 冻存液:90%FBS ,DMSO 10%, 或使用非程序冻存液:货号JY-H040 |
保藏机构 | DSMZ; ACC-701 |
产品使用 | 于科学研究 ,不可作为动物或人类疾病的治疗产品使用。 |
The aim of this study is to determine whether the pretreatment CD8+PD-1+ to CD4+PD-1+ (PERLS) ratio is an independent risk prognostic factor of advanced melanoma patients. We retrospectively analyzed the efficacy and flow cytometry data from advanced melanoma patients who received PD-1 inhibitor as monotherapy between January 1, 2018 and January 26, 2022. Fifty-nine patients were enrolled, the PERLS cutoff was 1.125. PERLS did not correlate with clinical characteristics but were significantly associated with baseline CD8+, CD4+, and CD8+PD-1+ T cells. The mean overall survival and the progression-free survival were 45.8 and 17.1 months for the low PERLS group (n = 39), compared with 29.9 (P = 0.001) and 9.7 (P = 0.003) months for the high PERLS group (n = 20), respectively. Pretreatment PERLS might contribute to selecting patients before receiving anti-PD-1 therapy.
请输入账号
请输入密码
请输验证码
以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,化工仪器网对此不承担任何保证责任。
温馨提示:为规避购买风险,建议您在购买产品前务必确认供应商资质及产品质量。